Written by Klarity Editorial Team
Published: May 9, 2026

If you’re a psychiatrist or PMHNP considering telehealth, you’ve probably asked: Can I actually prescribe antidepressants remotely? The short answer: yes — and in most cases, it’s no different than prescribing in-person. But the longer answer depends on your credentials, which state you’re practicing in, and whether you understand the current rules around telehealth prescribing.
Depression is one of the most common conditions you’ll treat in telepsychiatry. The medication management is straightforward — SSRIs, SNRIs, bupropion, mirtazapine — none of them are controlled substances, so you avoid the regulatory landmines that come with ADHD or chronic pain treatment. Telehealth has become the norm for mental health care (behavioral health telehealth is still 20+ times higher than pre-2019 levels), and both Medicare and commercial insurers are paying for virtual visits at the same rate as office visits in most states.
But there’s nuance. Your scope of practice matters. Psychiatrists (MD/DO) have universal prescribing authority. PMHNPs? That depends entirely on where your patient is sitting during the video call. Some states grant you full independence. Others require you to work under a supervising physician — even via telehealth.
Let’s break down what you need to know to prescribe depression medications through telehealth confidently and legally.
Here’s the good news: treating depression via telehealth is one of the least restricted areas of telepsychiatry. Why? Because first-line antidepressants aren’t controlled substances.
Under the Ryan Haight Act (the federal law governing online prescribing), controlled substances typically require an in-person exam before you can prescribe via telemedicine. But SSRIs, SNRIs, tricyclics, and most other depression medications don’t fall under DEA scheduling — so that rule doesn’t apply.
Even when you need to prescribe a controlled adjunct (say, a benzodiazepine for severe anxiety or trazodone for insomnia), temporary federal waivers have you covered. The DEA extended COVID-era flexibilities that allow prescribing controlled substances via telehealth without an initial in-person visit through at least the end of 2025. This gives you the freedom to manage complex cases — including patients with comorbid anxiety or treatment-resistant depression — all through secure video visits.
What this means practically:
The clinical workflow mirrors in-person care. You’re doing the same mental status exam, the same PHQ-9 screening, the same risk assessment. The only difference is the medium.
Key consideration: You must still meet the standard of care. That includes proper documentation, informed consent, suicide risk screening, and safety planning. Just because it’s telehealth doesn’t mean shortcuts.
Here’s the rule that trips up many providers: you must be licensed in the state where the patient is physically located during the telehealth visit.
This isn’t about where you are sitting. If you’re a New York-licensed psychiatrist doing a telehealth visit with a patient sitting in their apartment in Philadelphia, you need a Pennsylvania license. Period.
For psychiatrists, the good news is the Interstate Medical Licensure Compact (IMLC) now covers 37 states. If you’re eligible, it fast-tracks getting multiple state licenses, which lets you treat patients across a regional footprint. Texas, Florida, Illinois, Pennsylvania — all part of the Compact. That opens up massive patient volume if you’re willing to credential in multiple states.
For PMHNPs, state licensing works the same way — you need an NP license in the patient’s state. But here’s where it gets stickier: your scope of practice follows the patient’s state law, not yours.
That PMHNP with full practice authority in New York? If she treats a patient in Texas via telehealth, she’s suddenly operating under Texas’s restrictive supervision laws — which means she’d need a collaborating physician in Texas to prescribe legally.
This is the real complexity of multi-state telehealth for NPs. You’re not just getting licensed in multiple states; you’re navigating six different regulatory frameworks if you want to cover the major markets.
If you’re a psychiatrist, your authority is universal. You can evaluate, diagnose, and prescribe any medication for depression in any state where you hold a medical license. No supervision. No collaborative agreements. No formulary restrictions (beyond standard medical practice).
For PMHNPs, it’s a patchwork:
New York is the gold standard for NP autonomy. As of 2022, experienced PMHNPs (those with 3,600+ hours of practice) can prescribe independently — no physician oversight required. You’re practicing to the full extent of your training.
What this means: A PMHNP in New York treating depression via telehealth operates identically to a psychiatrist from a prescribing standpoint. You can manage the full spectrum — initiate SSRIs, switch to SNRIs, add atypicals, prescribe controlled substances when clinically indicated.
These states allow NPs to prescribe but require collaborative agreements with physicians.
Pennsylvania: You need a formal written agreement with a supervising physician. The physician doesn’t co-sign every prescription, but the relationship must be documented and filed with the State Board. For depression care, this is manageable — you can prescribe antidepressants, adjust doses, manage medication trials — but you’re operating under the umbrella of physician oversight.
Illinois: Similar setup, but Illinois offers a path to Full Practice Authority after 4,000 supervised hours. Once you obtain FPA status, you can practice independently — except for certain controlled substances (benzos, Schedule II stimulants), which still require physician consultation. For straightforward depression management (SSRIs, SNRIs, bupropion), FPA NPs in Illinois function like psychiatrists.
This is where NP practice gets constrained.
Texas: You cannot prescribe anything without a supervising physician and a formal Prescriptive Authority Agreement. The physician must review your charts regularly and be available for consultation. Texas also prohibits NPs from prescribing Schedule II controlled substances in most outpatient settings. For depression care specifically, you can prescribe antidepressants under supervision, but your autonomy is limited.
Florida: Similar story. Florida created ‘autonomous practice’ categories for NPs in 2020 — but only for primary care, not psychiatric NPs. PMHNPs still require a written protocol with a supervising physician. You can prescribe depression medications (and controlled substances, with some limits), but you’re tethered to physician oversight.
Bottom line: In restricted states, psychiatrists have a clear operational advantage. They can join a telehealth platform and start treating patients immediately. PMHNPs need the platform to arrange physician supervision — which adds administrative overhead but is still doable.
One of the biggest myths about telehealth is that it pays less than in-person care. For mental health, that’s largely false — thanks to telehealth parity laws.
As of 2025, 44 states plus DC mandate that private insurers cover telehealth, and 23 states explicitly require payment parity (same rate as in-person). New York, Illinois, California, Pennsylvania — all have strong parity provisions. Even Texas, despite its restrictive NP laws, has Medicaid telehealth parity.
What does a typical depression med management visit pay?
These are the same rates you’d get for seeing the patient in an office. Medicare follows the same principle — telehealth mental health visits are reimbursed at standard Physician Fee Schedule rates through at least 2025 (and likely beyond, given bipartisan support for extending telehealth coverage).
Psychiatrist vs PMHNP reimbursement:There’s one key difference. Medicare pays 85% of the physician fee schedule for NP services billed under the NP’s own NPI. So if a psychiatrist gets $115 for a 99214, an NP would get about $98 for the same visit.
For commercial payers, this varies — many pay NPs at 100% if they’re credentialed, but some still apply the 85% rule. It’s not a dealbreaker, but it’s worth knowing if you’re an NP negotiating compensation on a telehealth platform.
Why this matters for you:You’re not taking a pay cut to do telehealth. A well-run platform that handles patient acquisition and credentialing can actually increase your effective hourly rate — you’re eliminating drive time, overhead, and no-shows (since patients join from home).
Let’s talk about the elephant in the room: how do you actually get patients?
If you’re thinking about building your own telehealth practice, you’ve probably looked into SEO, Google Ads, Psychology Today listings, or Zocdoc. Here’s the brutal truth: acquiring a qualified psychiatric patient through DIY marketing costs $200–$500+ when you factor in all the hidden costs.
The real cost breakdown:
SEO: Takes 6–12 months of consistent investment before you see meaningful traffic. You’re paying an agency or consultant $2,000–$5,000/month, writing blog posts, optimizing your site — and you still won’t rank for competitive keywords like ‘psychiatrist near me’ for months. Most solo providers don’t have the budget or patience.
Google Ads: Mental health keywords cost $15–$40+ per click. Most clicks don’t convert. A realistic cost per booked patient (not just a click) is $200–$400+ after you account for ad spend, landing page optimization, and no-shows.
Psychology Today: You’re paying a monthly subscription ($29.95–$49.95/month) to be listed alongside hundreds of other providers in your area. Patients scroll through pages of profiles. You might get a few leads, but conversion is hit-or-miss.
Zocdoc: Charges a per-booking fee ($35–$100+ depending on specialty) plus a monthly platform fee. It’s effectively a pay-per-patient model — but you’re still competing with dozens of other providers on the same platform.
The hidden costs nobody talks about:
Add it all up, and you’re spending $3,000–$5,000/month on marketing with uncertain results.
Here’s where platforms like Klarity Health change the math entirely.
Instead of gambling on marketing channels, you pay a standard listing fee per qualified patient lead. Think of it like Zocdoc, but with better patient matching and built-in telehealth infrastructure.
The value proposition:
The economic reality:Instead of spending $3,000–$5,000/month on marketing hoping to get 10-15 new patients, you pay a per-patient fee and know exactly what your acquisition cost is. That’s guaranteed ROI.
For most providers — especially those starting out, scaling, or just tired of the admin burden of patient acquisition — this model removes all the risk.
Here’s the quick-reference guide for our six priority states:
Can I prescribe antidepressants on the first telehealth visit?
Yes — if you’re licensed in the patient’s state and conduct a proper evaluation. There’s no requirement for an in-person visit to prescribe non-controlled medications like SSRIs or SNRIs.
Do I need a DEA license for every state I practice in?
Yes. If you’re prescribing controlled substances (even as adjuncts to depression treatment), you need a DEA registration in each state where you treat patients.
What if I need to prescribe a benzodiazepine or stimulant via telehealth?
Under current federal waivers (extended through end of 2025), you can prescribe controlled substances via telehealth without an initial in-person visit. Permanent rules are expected by late 2025, but for now, you’re covered.
How do PMHNPs in restricted states practice via telehealth?
They need a collaborating physician in that state. The telehealth platform typically arranges this as part of onboarding, but it adds administrative overhead.
Does telehealth pay the same as in-person for medication management?
In most states, yes — thanks to telehealth parity laws. Medicare and most commercial payers reimburse telehealth E/M codes at the same rate as office visits.
Can I treat patients in multiple states simultaneously?
Yes, if you hold licenses in each state. Psychiatrists can use the Interstate Medical Licensure Compact to expedite multi-state licensing. NPs need to apply for licensure in each state individually.
What’s the biggest mistake providers make with telehealth prescribing?
Assuming their home state license covers patients in other states. It doesn’t. Always verify you’re licensed where the patient is located during the visit.
If you’re a psychiatrist or PMHNP looking to treat depression patients via telehealth, Klarity Health offers the cleanest path to practice:
For Psychiatrists:
For PMHNPs:
For Both:Instead of spending thousands on marketing with no guarantees, you pay only when you see a qualified patient. That’s the model that makes economic sense — especially in a field with as much demand as depression treatment.
The demand is there. The reimbursement is solid. The regulations are clear (once you understand them).
Whether you’re a psychiatrist looking to expand your reach across state lines or a PMHNP wanting to practice to the full extent of your training, telehealth is the most flexible, scalable way to build your practice.
Explore Klarity Health’s provider network and see how our platform handles patient acquisition, credentialing, and telehealth infrastructure — so you can focus on what you do best: treating patients.
California Legislative Information – AB 890 (2020): www.leginfo.legislature.ca.gov
Florida Legislature – HB 607 (APRN Autonomous Practice, 2020): www.flsenate.gov
Florida Association of Nurse Practitioners – Past New Laws: www.flanp.org
American Association of Nurse Practitioners – State Practice Environment (Texas, California, Pennsylvania, Illinois, New York, Florida): www.aanp.org
JD Supra – New York NP Practice Law (2022): www.jdsupra.com
Texas Nurse Practitioners – DEA Telemedicine Extension: texasnp.org
Axios – Telehealth Prescribing Extended (Nov 2024): www.axios.com
iCanotes – Telehealth Parity Laws (2022–2025): www.icanotes.com
PayerPrice – CPT 99214 Reimbursement Rates: payerprice.com
LegalClarity – Medicare NP Coverage and Reimbursement: legalclarity.org
Healing Psychiatry Florida – Psychiatrist Shortage by State (2024–2026 data): www.healingpsychiatryflorida.com
AARP Texas – Healthcare Access Bill (SB 1700, 2023): www.aarp.org
Kiplinger – Medicare Telehealth in 2025: www.kiplinger.com
Time Magazine – Medicare Telehealth Extension (2025): time.com
Nurse Practitioner Practice Authority Updates (2026): www.nursepractitioneronline.com
(All sources accessed and verified February 2026)
Find the right provider for your needs — select your state to find expert care near you.